|
| Walter J Koroshetz | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Leslie M Shaw | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Hubert H Fernandez | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Matthew J Huentelman | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Horacio Kaufmann | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Eliezer Masliah | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Eliezer Masliah | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| David Robertson | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |
| Jeremy D Schmahmann | Barrow Neurological Institute, Medical University Innsbruck, Austria National Institute of Neurological Disorders and Stroke (W.R.G., Mayo Clinic, Sydney Medical School, the University of Sydney UNSW Medicine & Neuroscience Research Australia (G.H.), UCL Institute of Neurology (N.P.Q.), INSERM, and CHU de Toulouse (O.R.), University de Toulouse Centre de Reference Maladie Rare contre l'AMS (O.R.), Departments de Pharmacologie Clinique et de Neurosciences, Perelman School of Medicine, University of Pennsylvania, Philadelphia Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Inc. (P. B., NC Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Teva Pharmaceuticals, David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, MI Center for Neurological Restoration (H.F.), Cleveland Clinic, Beth Israel Deaconess Medical Center, Harvard Medical School, Hertie Institute of Clinical Brain Research, University of Tubingen German Center for Neurodegenerative Diseases (DZNE) (T.G.), Germany Lundbeck LLC (A.H.), IL German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Technical University of Munich, The Translational Genomics Research Institute, Aarhus University, Columbia University Medical Center Department of Neurology (H.K.), New York University School of Medicine, New York Whitehead Institute for Biomedical Research (V.K.), Cambridge Ann Romney Center for Neurologic Disease (V.K.), Brigham and Women's Hospital and Harvard Medical School, Boston Harvard Stem Cell Institute (V.K.), University of Bonn German Center for Neurodegenerative Diseases (DZNE) (T.K.), University of Sydney, Henry Ford Hospital Department of Neurology (P.L.), Wayne State University School of Medicine, National Institute on Aging/NIH, CHU de Bordeaux Universite de Bordeaux (W.M.), Institut des Maladies Neurodegeneratives, Bordeaux Paris Saclay Institute of Neuroscience (R.M.), CNRS, France Genentech Inc. (S.O.), South San Francisco Cedars-Sinai Medical Center (S.P.), Vanderbilt University Medical Center, The Ottawa Hospital, Massachusetts General Hospital, MA Cure MSA Foundation (L.S.), Rush University Medical Center, Graduate School of Medicine, Tokyo University, Japan and University of Washington (J.Z.) |